Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis
about
Sub-Optimal Treatment of Bacterial BiofilmsAn overview of international literature from cystic fibrosis registries. Part 5: Update 2012-2015 on lung disease.Ecological networking of cystic fibrosis lung infections.Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients.Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical responseStaphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosisReactive oxygen species drive evolution of pro-biofilm variants in pathogens by modulating cyclic-di-GMP levels.Tobramycin inhalation powder: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.Colistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.The problems of antibiotic resistance in cystic fibrosis and solutions.Bacterial Adaptation during Chronic Respiratory Infections.Relative resistance index (RRI) - a scoring system for antibiotic resistance in Pseudomonas aeruginosa.Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.Evaluation of phytochemicals from medicinal plants of Myrtaceae family on virulence factor production by Pseudomonas aeruginosa.Fusion between fluid liposomes and intact bacteria: study of driving parameters and in vitro bactericidal efficacy.Potential of host defense peptide prodrugs as neutrophil elastase-dependent anti-infective agents for cystic fibrosis.The emergence of multidrug-resistant Pseudomonas aeruginosa in cystic fibrosis patients on inhaled antibiotics.Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications.Prevalence of integrons 1, 2, 3 associated with antibiotic resistance in Pseudomonas aeruginosa isolates from Northwest of Iran.Primum non nocere.Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.
P2860
Q26747423-3F9F4D93-B1F6-47EF-B9BA-04120B7074F3Q30244524-6772D569-4D59-4423-9904-C37DE9104F5CQ33767505-79296FBA-151E-43C8-BEB3-2DE0B9A82FF5Q34106186-E1DEF6B8-9690-45B6-8165-788DB69F8B56Q34565049-BCF0DEF8-7FBA-42CA-BAA4-85AF1441A7C8Q35358667-6ED9C430-94D9-40F3-A837-1573B6E3DE9DQ37463364-29183D7D-CA12-43C9-AF8A-5092C8C61A93Q37464130-44A23FDA-FAB7-42AA-B31A-A0EE615B089EQ38160206-27FD9201-C88A-40B6-87DD-17B2F4914B2EQ38186636-A339DC1D-9DBB-4D40-B106-D48DD7C13AEEQ38300820-DB952600-7A5B-491E-A6F2-6FCB7963AB07Q38367560-7C043C35-DB90-481B-A236-A8E5056D336BQ40119316-E888F141-7CF1-448B-BBF2-0412344A9EB2Q40164055-B0555734-9940-4528-94B8-0E236BD4A5C3Q40293873-6D24A3AD-DC08-40F2-A2A1-7D79AFEB770DQ41459292-0E963DF8-7B0D-480A-871C-3C0C190578EDQ41907587-2CF71F4E-5888-4620-BB13-2C46297CFDBEQ45375226-F3C1B5E2-A891-4BE8-9F36-4A0C5EF34400Q47641904-49A1A6AF-C422-472F-B55A-A39E1BABC247Q50318621-BC3C3238-B0A2-458B-9A94-7C7D558F2B7AQ51555262-BA728697-88E8-4228-B524-63A19BCE1AE8Q55433449-FAEFB6E1-508E-4824-8621-0A6E4A15BA92
P2860
Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Multiple antibiotic-resistant ...... patients with cystic fibrosis
@ast
Multiple antibiotic-resistant ...... patients with cystic fibrosis
@en
type
label
Multiple antibiotic-resistant ...... patients with cystic fibrosis
@ast
Multiple antibiotic-resistant ...... patients with cystic fibrosis
@en
prefLabel
Multiple antibiotic-resistant ...... patients with cystic fibrosis
@ast
Multiple antibiotic-resistant ...... patients with cystic fibrosis
@en
P2093
P2860
P1476
Multiple antibiotic-resistant ...... patients with cystic fibrosis
@en
P2093
Ashley Yegin
Benjamin Trzaskoma
Clement L Ren
Lawrence Rasouliyan
Michael W Konstan
Scientific Advisory Group, Inv ...... logic Study of Cystic Fibrosis
Warren Regelmann
Wayne J Morgan
P2860
P304
P356
10.1016/J.JCF.2012.02.005
P577
2012-03-23T00:00:00Z